1[1]Thompson S G, Martin J C, Meade T W. Sources of variability in coagulation factor assays. Thromb Haemost, 1989, 58: 1073-1077.
2[2]Humphries S E, Temple A, Lane A, et al. Low plasma levels of factor ⅦC and antigen are more strongly associated with 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost, 1996, 75: 567-572.
3[3]Lievers K J, Mennen L I, Rattink A P, et al. The -323 Ins 10 polymorphism for factor Ⅶ is not associated with coronary atherosclerosis in symptomatic men. The REGRESS study group. Thromb Res. 2000,97:275-280.
3Di Castelnuovo A, Amore C, Amore C, et al. Genetic modulation of coagulation factor VR plasma leveis : contribution of different polymorphisms and gender-related effects [ J ]. Thrombosis and Haemostasis, 1998,80:592 - 597.
4Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor Ⅶ gene and the risk of myocardial infarction in patients with coronary artery disease [J]. N Engl J Med, 2000, 343:774-780.
5Steve H,Anne T, Anne L, et al. Low plasma levels of factor Ⅶc and antigen are most strongly associated with the 10 base pair promoter ( - 323 ) insertion than the Glutamine 353 variant [ J ]. Thrombosis and Haemostasis, 1996,75:567 -572.
6Nour M, Slama FB, Monastiri K, et al. Prevalence in a Tunisian Arabic population of factor VII DNA variants and relation to factor Ⅶ plasma levels [J]. Clin Chim Acta, 2004,349:199 -202.
7Junker R,Heinrich J,Schulte H,et al.Coagulation factor Ⅶ and the risk of coronary heart disease in healthy men Arterioscler Thromb,1997,17(8):1539-1544.
8Cooper JA,Miller GJ,Bauer KA,et al.Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.Circulation,2000,102(23):1524-4539.
9Eigenbrot C.Structrue,function and activation of coagulation factor Ⅶ.Curt Protein Pet Sci,2002,3(3):287-299.
10Doggen CJM,Rosendaal FR.Levels of factor Ⅶ and the risk of myocardial infarction.Thromb Haemost,2001,Suppl:2864.
